PCYT1B and neoplasm: Consistent with this, lower PC levels in the liver of mice with liver-specific knockout of PCYT1B decreased tumor burden, TG levels, and mTORC signaling in the liver, while PC administration abolished these effects (Supplemental Figure 13, A–F).